In conclusion, the review illustrated a direct link between miRNAs and nuclear receptor PPARs in the context of PH, vascular dysfunction, heart diseases, and obesity-related cardiovascular risks and demonstrated that targeting the miRNA/PPAR axis may represent a novel therapeutic approach for CVDs. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.